Medication info

Bisral Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Ixu Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201904822 · Approved 2019.07.18

This product's status changed to Expired on 2024.07.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers), Zollinger-Ellison syndrome, and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug administration or for prevention of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration generally heal within 4 weeks, and usually within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In cases of severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Ixu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers), Zollinger-Ellison syndrome, and prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcer
  • gastric ulcer caused by non-steroidal anti-inflammatory drugs
  • duodenal ulcer caused by non-steroidal anti-inflammatory drugs
View approved original text

This medication is used to treat gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also assists in the prevention of Mendelson syndrome prior to anesthesia and helps prevent postoperative ulcers. It is effective in treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to improve various gastrointestinal diseases.

How to take

Adult dose

○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug administration or for prevention of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration generally heal within 4 weeks, and usually within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In cases of severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This drug should not be used in patients undergoing dialysis or those with impaired kidney function. Additionally, it should not be administered to patients with a history of allergic reactions to this drug or its components, those with acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants and neonates, and patients who need to restrict potassium intake. Caution should be exercised in patients with poor liver function or a history of hypersensitivity, elderly patients, patients with a history of kidney disorders, and those taking non-steroidal anti-inflammatory drugs. Particularly, it may mask symptoms of stomach cancer; therefore, gastric ulcer patients or middle-aged patients who recently experience new dyspeptic symptoms should be given this medication only after confirming the malignancy. Patients with gastric or duodenal ulcers caused by Helicobacter pylori require eradication therapy, and patients in severe intensive care or those with hypophosphatemia should also be cautious. While taking this medication, there may be rare occurrences of allergic reactions, blood abnormalities, hepatic impairment, arrhythmias, gastrointestinal symptoms, neurological symptoms, musculoskeletal pain, and skin rashes. Therefore, it is recommended to consult a healthcare professional immediately if any abnormal symptoms occur. Long-term use should be avoided, treatment progress should be monitored regularly, and only the minimum effective dose should be used. Elderly patients or those with chronic diseases are at an increased risk for pneumonia; thus, caution is necessary, and if dizziness or drowsiness occurs, avoiding driving or operating hazardous machinery is advisable. This medication may interact with other drugs, so if you are taking any other medications, be sure to inform your healthcare provider. Pregnant or breastfeeding women are advised against using this medication, and its safety in children has not been established, thus administration to children should be avoided. In case of overdose, emergency treatment such as vomiting or gastric lavage should be sought, and if necessary, blood dialysis can be performed for removal. Finally, this drug can decrease gastric acid secretion and promote bacterial proliferation in the stomach, so regular check-ups, including eye examinations, are needed during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 59 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sensation
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • myoclonic jerks
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.